DEVAZEPIDE

Devazepide A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.

Molecular Formula: C₂₅H₂₀N₄O₂

InChI: InChI=1/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/f/h28H

InChIKey: InChIKey=NFHRQQKPEBFUJK-LBOYIXSDCR
SMILES: CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C3=CC4=CC=CC=C4N3)C5=CC=CC=C5

Names:
    BRN 5156082
    Devazepida [INN-Spanish]
    Devazepide [USAN:INN]
    DEVAZEPIDE
    Devazepidum [INN-Latin]
    L 364718
    MK-329
    N-(2-methyl-3-oxo-6-phenyl-2,5-diazabicyclo[5.4.0]undeca-5,7,9,11-tetraen-4-yl)-1H-indole-2-carboxamide
    (S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide
    1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-
    103420-77-5

Registries:
    PubChem CID 59751
    PubChem ID 196220